Tag: AbbVie

Finance

DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY), AbbVie Inc (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ)

Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site. In a joint announcement, Gov. Dannel P. Malloy and Pfizer confirmed that two buildings on the company’s campus will be donated for use in … Continue reading DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY), AbbVie Inc (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ)

Chris Lewis
Finance

Trader’s Alert: AbbVie Inc (NYSE:ABBV), NeoStem Inc (NASDAQ:NBS), Occidental Petroleum Corporation (NYSE:OXY), Wells Fargo & Co (NYSE:WFC)

AbbVie, Inc. (NYSE:ABBV) announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need. Currently there are no approved treatments for fingernail psoriasis. AbbVie Inc (NYSE:ABBV) stock performance was 1.07% in last session and finished the day at … Continue reading Trader’s Alert: AbbVie Inc (NYSE:ABBV), NeoStem Inc (NASDAQ:NBS), Occidental Petroleum Corporation (NYSE:OXY), Wells Fargo & Co (NYSE:WFC)

Jason Knox
BioTech, Finance

Shire Rejects a $46.5 Billion AbbVie (NYSE:ABBV) Takeover Offer

Goldman Sachs has been hired by Shire as the London-listed drug maker confronts a takeover offer, as explained in the Financial Times morning briefing. Shire turned down a $46 billion bid from Chicago-based AbbVie last week. According to a report from the New-York Times, people briefed on the matter said AbbVie was likely to come back with a higher offer. Allergan, which is fending off … Continue reading Shire Rejects a $46.5 Billion AbbVie (NYSE:ABBV) Takeover Offer

Harvey Dyer